SCPX logo

Scorpius Holdings, Inc. Stock Price

OTCPK:SCPX Community·US$550.3k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

SCPX Share Price Performance

US$0.009
-0.64 (-98.61%)
US$0.009
-0.64 (-98.61%)
Price US$0.009

SCPX Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
0 Rewards

Scorpius Holdings, Inc. Key Details

US$2.9m

Revenue

US$16.2m

Cost of Revenue

-US$13.3m

Gross Profit

US$25.8m

Other Expenses

-US$39.1m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
-0.64
-452.08%
-1,329.49%
-204.7%
View Full Analysis

About SCPX

Founded
2008
Employees
91
CEO
Jeffrey Wolf
WebsiteView website
www.scorpiusbiologics.com

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.

Recent SCPX News & Updates

Recent updates

No updates